It’s amazing that just because my stupid fat thumb touched an ad on a recipe site I will now be hammered by ads for “elinzanetant” all over my usage of Al Gore’s internet.
You know, for my menopause hot flashes!
Quite a stupid world we’ve built here.
You know, for my menopause hot flashes!
Quite a stupid world we’ve built here.
December 28, 2025 at 8:29 PM
It’s amazing that just because my stupid fat thumb touched an ad on a recipe site I will now be hammered by ads for “elinzanetant” all over my usage of Al Gore’s internet.
You know, for my menopause hot flashes!
Quite a stupid world we’ve built here.
You know, for my menopause hot flashes!
Quite a stupid world we’ve built here.
Answer: C. Suzetrigine is a sodium channel blocker indicated for M/S acute pain.
Elinzanetant is a neurokinin 1 and neurokinin 3 receptor antagonist for M/S vasomotor symptoms due to menopause.
Riboflavin 5’-phosphate is a corneal cross-linking …
Continued
2/3
Elinzanetant is a neurokinin 1 and neurokinin 3 receptor antagonist for M/S vasomotor symptoms due to menopause.
Riboflavin 5’-phosphate is a corneal cross-linking …
Continued
2/3
December 22, 2025 at 2:24 PM
Answer: C. Suzetrigine is a sodium channel blocker indicated for M/S acute pain.
Elinzanetant is a neurokinin 1 and neurokinin 3 receptor antagonist for M/S vasomotor symptoms due to menopause.
Riboflavin 5’-phosphate is a corneal cross-linking …
Continued
2/3
Elinzanetant is a neurokinin 1 and neurokinin 3 receptor antagonist for M/S vasomotor symptoms due to menopause.
Riboflavin 5’-phosphate is a corneal cross-linking …
Continued
2/3
Which novel drug approved in 2025 treats moderate to severe pain?
A. Elinzanetant (Lynkuet)
B. Riboflavin 5’-phosphate (Epioxa)
C. Suzetrigine (Journavx)
D. Vimseltinib (Romvimza)
The answer is in the thread 1/3
#PhunQuiz
A. Elinzanetant (Lynkuet)
B. Riboflavin 5’-phosphate (Epioxa)
C. Suzetrigine (Journavx)
D. Vimseltinib (Romvimza)
The answer is in the thread 1/3
#PhunQuiz
December 22, 2025 at 2:24 PM
Which novel drug approved in 2025 treats moderate to severe pain?
A. Elinzanetant (Lynkuet)
B. Riboflavin 5’-phosphate (Epioxa)
C. Suzetrigine (Journavx)
D. Vimseltinib (Romvimza)
The answer is in the thread 1/3
#PhunQuiz
A. Elinzanetant (Lynkuet)
B. Riboflavin 5’-phosphate (Epioxa)
C. Suzetrigine (Journavx)
D. Vimseltinib (Romvimza)
The answer is in the thread 1/3
#PhunQuiz
Elinzanetant (Lynkuet) for Menopausal Vasomotor Symptoms
Free access: medicalletter.org/elinz744b
Free access: medicalletter.org/elinz744b
December 15, 2025 at 9:09 PM
Elinzanetant (Lynkuet) for Menopausal Vasomotor Symptoms
Free access: medicalletter.org/elinz744b
Free access: medicalletter.org/elinz744b
Nonhormonal therapies for menopausal hot flashes are changing care. Fezolinetant and elinzanetant target brain pathways, offering effective relief for women who can’t take estrogen. #MenopauseCare #HotFlashes
Full video: www.contemporaryobgyn.net/view/genevie...
Full video: www.contemporaryobgyn.net/view/genevie...
December 9, 2025 at 9:57 PM
Nonhormonal therapies for menopausal hot flashes are changing care. Fezolinetant and elinzanetant target brain pathways, offering effective relief for women who can’t take estrogen. #MenopauseCare #HotFlashes
Full video: www.contemporaryobgyn.net/view/genevie...
Full video: www.contemporaryobgyn.net/view/genevie...
Bayer’s Lynkuet (elinzanetant) approved in the EU as the first hormone-free treatment for vasomotor symptoms (VMS).
🔗 Full article: stellanews.life/technology_c...
🔗 Full article: stellanews.life/technology_c...
Lynkuet（エリンザネタント）、EUで承認 閉経および乳がん内分泌療法に伴う中等度～重度VMSに対応する初のホルモンフリー治療薬 | STELLANEWS.LIFE
Lynkuet（エリンザネタント）は、NK-1／NK-3受容体を標的とする経口非ホルモン治療薬として、欧州連合で閉経および乳がん補助内分泌療法に伴う血管運動症状（VMS）の治療薬として承認された。OASIS第3相プログラムに基づく初の技術。
stellanews.life
November 24, 2025 at 9:22 PM
Bayer’s Lynkuet (elinzanetant) approved in the EU as the first hormone-free treatment for vasomotor symptoms (VMS).
🔗 Full article: stellanews.life/technology_c...
🔗 Full article: stellanews.life/technology_c...
Also approved in Canada and the United Kingdom, elinzanetant is the first non-hormonal medicine shown to reduce hot flashes in people with a history of breast cancer. 💊 https://bit.ly/4pqHUaz
#Menopause #BreastCancer #HotFlashes
#Menopause #BreastCancer #HotFlashes
November 24, 2025 at 3:56 PM
Also approved in Canada and the United Kingdom, elinzanetant is the first non-hormonal medicine shown to reduce hot flashes in people with a history of breast cancer. 💊 https://bit.ly/4pqHUaz
#Menopause #BreastCancer #HotFlashes
#Menopause #BreastCancer #HotFlashes
Elinzanetant, antagonista del receptor 1 y 3 de neuroquinina, reduce frecuencia y gravedad de manifestaciones en pacientes con síntomas vasomotores graves asociados con la menopausia o causados por la terapia endocrina adyuvante relacionada con el cáncer de mama firstwordpharma.com/story/6681293
firstwordpharma.com
November 24, 2025 at 7:22 AM
Elinzanetant, antagonista del receptor 1 y 3 de neuroquinina, reduce frecuencia y gravedad de manifestaciones en pacientes con síntomas vasomotores graves asociados con la menopausia o causados por la terapia endocrina adyuvante relacionada con el cáncer de mama firstwordpharma.com/story/6681293
Elinzanetant is a dual NK1R/NK3R antagonist approved in October 2025 for the treatment of moderate to severe VMS due to menopause.
Check out the full case study on Drug Hunter: drughunter.com/molecule/eli...
Check out the full case study on Drug Hunter: drughunter.com/molecule/eli...
November 19, 2025 at 8:59 PM
Elinzanetant is a dual NK1R/NK3R antagonist approved in October 2025 for the treatment of moderate to severe VMS due to menopause.
Check out the full case study on Drug Hunter: drughunter.com/molecule/eli...
Check out the full case study on Drug Hunter: drughunter.com/molecule/eli...
O FDA aprovou em outubro de 2025 o Elinzanetant, primeiro medicamento não hormonal para tratar sintomas da menopausa como ondas de calor e suores noturnos. Desenvolvido pela Bayer.
Matéria completa - regisandrade.com.br/fda-aprova-e...
#Elinzanetant #menopausa #FDA
Matéria completa - regisandrade.com.br/fda-aprova-e...
#Elinzanetant #menopausa #FDA
November 12, 2025 at 12:33 PM
O FDA aprovou em outubro de 2025 o Elinzanetant, primeiro medicamento não hormonal para tratar sintomas da menopausa como ondas de calor e suores noturnos. Desenvolvido pela Bayer.
Matéria completa - regisandrade.com.br/fda-aprova-e...
#Elinzanetant #menopausa #FDA
Matéria completa - regisandrade.com.br/fda-aprova-e...
#Elinzanetant #menopausa #FDA
Episode 193: Intensive BP lowering, elinzanetant for vasomotor symptoms, HTN in pregnancy and prostate CA screening.
#NAPCRG #STFM #AAFP #PrimaryCare #FamilyMedicine #EssentialEvidencePlus #InfoPOEMs
spotifycreators-web.app.link/e/50uojPZMdYb
#NAPCRG #STFM #AAFP #PrimaryCare #FamilyMedicine #EssentialEvidencePlus #InfoPOEMs
spotifycreators-web.app.link/e/50uojPZMdYb
Episode 193: Intensive BP lowering, elinzanetant for VMS, HTN in pregnancy and prostate CA screening by Primary Care Update
Primary care physicians Gary Ferenchick, Kate Rowland, Henry Barry and Mark Ebell want you to know about 4 new studies: the best choice of pharmacotherapy in hypertensive disorders of pregnancy, benef...
spotifycreators-web.app.link
November 12, 2025 at 12:16 AM
Episode 193: Intensive BP lowering, elinzanetant for vasomotor symptoms, HTN in pregnancy and prostate CA screening.
#NAPCRG #STFM #AAFP #PrimaryCare #FamilyMedicine #EssentialEvidencePlus #InfoPOEMs
spotifycreators-web.app.link/e/50uojPZMdYb
#NAPCRG #STFM #AAFP #PrimaryCare #FamilyMedicine #EssentialEvidencePlus #InfoPOEMs
spotifycreators-web.app.link/e/50uojPZMdYb
✨Clinical Success for Lynkuet (Elinzanetant)!✨
💊Those taking the Lynkuet for 12 weeks reported a 73% reduction in the frequency of 𝗵𝗼𝘁 𝗳𝗹𝗮𝘀𝗵𝗲𝘀 & 𝗻𝗶𝗴𝗵𝘁 𝘀𝘄𝗲𝗮𝘁𝘀, compared to a 47% reduction in the placebo group.
💊Those taking the Lynkuet for 12 weeks reported a 73% reduction in the frequency of 𝗵𝗼𝘁 𝗳𝗹𝗮𝘀𝗵𝗲𝘀 & 𝗻𝗶𝗴𝗵𝘁 𝘀𝘄𝗲𝗮𝘁𝘀, compared to a 47% reduction in the placebo group.
November 9, 2025 at 6:09 PM
✨Clinical Success for Lynkuet (Elinzanetant)!✨
💊Those taking the Lynkuet for 12 weeks reported a 73% reduction in the frequency of 𝗵𝗼𝘁 𝗳𝗹𝗮𝘀𝗵𝗲𝘀 & 𝗻𝗶𝗴𝗵𝘁 𝘀𝘄𝗲𝗮𝘁𝘀, compared to a 47% reduction in the placebo group.
💊Those taking the Lynkuet for 12 weeks reported a 73% reduction in the frequency of 𝗵𝗼𝘁 𝗳𝗹𝗮𝘀𝗵𝗲𝘀 & 𝗻𝗶𝗴𝗵𝘁 𝘀𝘄𝗲𝗮𝘁𝘀, compared to a 47% reduction in the placebo group.
Clinical trials for 𝗘𝗹𝗶𝗻𝘇𝗮𝗻𝗲𝘁𝗮𝗻𝘁 have been incredibly positive. In a Phase 3 trial with postmenopausal women
#snowdenlitos #Lynkuet #Elinzanetant #MenopauseRelief #NonHormonal #HotFlashRelief #WomensHealth #MenopauseCare #FDAApproved #menopauseeducation #premenopausematters #hormonehealth
#snowdenlitos #Lynkuet #Elinzanetant #MenopauseRelief #NonHormonal #HotFlashRelief #WomensHealth #MenopauseCare #FDAApproved #menopauseeducation #premenopausematters #hormonehealth
November 9, 2025 at 6:08 PM
Clinical trials for 𝗘𝗹𝗶𝗻𝘇𝗮𝗻𝗲𝘁𝗮𝗻𝘁 have been incredibly positive. In a Phase 3 trial with postmenopausal women
#snowdenlitos #Lynkuet #Elinzanetant #MenopauseRelief #NonHormonal #HotFlashRelief #WomensHealth #MenopauseCare #FDAApproved #menopauseeducation #premenopausematters #hormonehealth
#snowdenlitos #Lynkuet #Elinzanetant #MenopauseRelief #NonHormonal #HotFlashRelief #WomensHealth #MenopauseCare #FDAApproved #menopauseeducation #premenopausematters #hormonehealth
✨How Lynkuet (Elinzanetant) Works✨
Did you know that hot flashes are triggered by tiny chemical messengers in the brain called 𝗻𝗲𝘂𝗿𝗼𝗸𝗶𝗻𝗶𝗻𝘀?
#snowdenlitos #Lynkuet #Elinzanetant #MenopauseRelief #NonHormonal #HotFlashRelief #WomensHealth #MenopauseCare #FDAApproved #womenshealtheducation
Did you know that hot flashes are triggered by tiny chemical messengers in the brain called 𝗻𝗲𝘂𝗿𝗼𝗸𝗶𝗻𝗶𝗻𝘀?
#snowdenlitos #Lynkuet #Elinzanetant #MenopauseRelief #NonHormonal #HotFlashRelief #WomensHealth #MenopauseCare #FDAApproved #womenshealtheducation
November 7, 2025 at 8:23 PM
✨How Lynkuet (Elinzanetant) Works✨
Did you know that hot flashes are triggered by tiny chemical messengers in the brain called 𝗻𝗲𝘂𝗿𝗼𝗸𝗶𝗻𝗶𝗻𝘀?
#snowdenlitos #Lynkuet #Elinzanetant #MenopauseRelief #NonHormonal #HotFlashRelief #WomensHealth #MenopauseCare #FDAApproved #womenshealtheducation
Did you know that hot flashes are triggered by tiny chemical messengers in the brain called 𝗻𝗲𝘂𝗿𝗼𝗸𝗶𝗻𝗶𝗻𝘀?
#snowdenlitos #Lynkuet #Elinzanetant #MenopauseRelief #NonHormonal #HotFlashRelief #WomensHealth #MenopauseCare #FDAApproved #womenshealtheducation
Bayer’s Lynkuet (elinzanetant) has received FDA approval to treat moderate to severe vasomotor symptoms including hot flashes and night sweats, during menopause.
🔍 Explore the clinical evidence for Lynkuet at DRUGDOCS® drugdocs.com/drug/Lynkuet
#FDA #PharmaUpdate #MenopauseTreatment #DrugDocs
🔍 Explore the clinical evidence for Lynkuet at DRUGDOCS® drugdocs.com/drug/Lynkuet
#FDA #PharmaUpdate #MenopauseTreatment #DrugDocs
November 7, 2025 at 3:47 PM
Bayer’s Lynkuet (elinzanetant) has received FDA approval to treat moderate to severe vasomotor symptoms including hot flashes and night sweats, during menopause.
🔍 Explore the clinical evidence for Lynkuet at DRUGDOCS® drugdocs.com/drug/Lynkuet
#FDA #PharmaUpdate #MenopauseTreatment #DrugDocs
🔍 Explore the clinical evidence for Lynkuet at DRUGDOCS® drugdocs.com/drug/Lynkuet
#FDA #PharmaUpdate #MenopauseTreatment #DrugDocs
RCT: In postmenopausal women, elinzanetant reduced vasomotor symptoms compared to placebo at 12 weeks, with continued benefits in frequency, sleep, and quality of life over 52 weeks, while maintaining safety. ja.ma/4hH0lE8
November 7, 2025 at 1:00 PM
RCT: In postmenopausal women, elinzanetant reduced vasomotor symptoms compared to placebo at 12 weeks, with continued benefits in frequency, sleep, and quality of life over 52 weeks, while maintaining safety. ja.ma/4hH0lE8
Philadelphia doctors call menopause drug elinzanetant promising
https://www.newsbeep.com/us-pa/26640/
New treatment for menopause hot flashes and night sweats Women who experience menopause symptoms can have them briefly…
https://www.newsbeep.com/us-pa/26640/
New treatment for menopause hot flashes and night sweats Women who experience menopause symptoms can have them briefly…
Philadelphia doctors call menopause drug elinzanetant promising - Pennsylvania News Beep
New treatment for menopause hot flashes and night sweats
www.newsbeep.com
November 6, 2025 at 1:40 PM
Philadelphia doctors call menopause drug elinzanetant promising
https://www.newsbeep.com/us-pa/26640/
New treatment for menopause hot flashes and night sweats Women who experience menopause symptoms can have them briefly…
https://www.newsbeep.com/us-pa/26640/
New treatment for menopause hot flashes and night sweats Women who experience menopause symptoms can have them briefly…
Introducing 𝗟𝘆𝗻𝗸𝘂𝗲𝘁 (𝗘𝗹𝗶𝗻𝘇𝗮𝗻𝗲𝘁𝗮𝗻𝘁) once-daily, non-hormonal treatment recently approved by the U.S. FDA for 𝗺𝗼𝗱𝗲𝗿𝗮𝘁𝗲 𝘁𝗼 𝘀𝗲𝘃𝗲𝗿𝗲 𝗵𝗼𝘁 𝗳𝗹𝗮𝘀𝗵𝗲𝘀 𝗮𝗻𝗱 𝗻𝗶𝗴𝗵𝘁 𝘀𝘄𝗲𝗮𝘁𝘀.
November 4, 2025 at 4:03 PM
Introducing 𝗟𝘆𝗻𝗸𝘂𝗲𝘁 (𝗘𝗹𝗶𝗻𝘇𝗮𝗻𝗲𝘁𝗮𝗻𝘁) once-daily, non-hormonal treatment recently approved by the U.S. FDA for 𝗺𝗼𝗱𝗲𝗿𝗮𝘁𝗲 𝘁𝗼 𝘀𝗲𝘃𝗲𝗿𝗲 𝗵𝗼𝘁 𝗳𝗹𝗮𝘀𝗵𝗲𝘀 𝗮𝗻𝗱 𝗻𝗶𝗴𝗵𝘁 𝘀𝘄𝗲𝗮𝘁𝘀.
✨New option for menopause relief!
#FDAapproved Lynkuet (Elinzanetant), a once-daily #nonhormonaltreatment for #moderatetoseverehotflashes&nightsweats arrives Nov 2025.
Hormone-free comfort, balance & confidence.🌿
🔗 snowdenlitos.com/lynkuet-blog/
#Lynkuet #MenopauseRelief #NonHormonal #WomensHealth
#FDAapproved Lynkuet (Elinzanetant), a once-daily #nonhormonaltreatment for #moderatetoseverehotflashes&nightsweats arrives Nov 2025.
Hormone-free comfort, balance & confidence.🌿
🔗 snowdenlitos.com/lynkuet-blog/
#Lynkuet #MenopauseRelief #NonHormonal #WomensHealth
November 4, 2025 at 4:01 PM
✨New option for menopause relief!
#FDAapproved Lynkuet (Elinzanetant), a once-daily #nonhormonaltreatment for #moderatetoseverehotflashes&nightsweats arrives Nov 2025.
Hormone-free comfort, balance & confidence.🌿
🔗 snowdenlitos.com/lynkuet-blog/
#Lynkuet #MenopauseRelief #NonHormonal #WomensHealth
#FDAapproved Lynkuet (Elinzanetant), a once-daily #nonhormonaltreatment for #moderatetoseverehotflashes&nightsweats arrives Nov 2025.
Hormone-free comfort, balance & confidence.🌿
🔗 snowdenlitos.com/lynkuet-blog/
#Lynkuet #MenopauseRelief #NonHormonal #WomensHealth
New menopause drug without hormones approved by FDA. A doctor shares what to know. https://www.cbsnews.com/texas/news/menopause-drug-without-hormones-lynkuet-elinzanetant-approved-fda/
New menopause drug without hormones approved by FDA. A doctor shares what to know.
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot flashes due to menopause.
www.cbsnews.com
November 2, 2025 at 11:09 AM
New menopause drug without hormones approved by FDA. A doctor shares what to know. https://www.cbsnews.com/texas/news/menopause-drug-without-hormones-lynkuet-elinzanetant-approved-fda/
Seattle Clinical Research Center Recognizes FDA Approval of Elinzanetant (Lynkuet) for Moderate to Severe Hot Flashes Following Clinical Trial Participation
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand…
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand…
Seattle Clinical Research Center Recognizes FDA Approval of Elinzanetant (Lynkuet) for Moderate to Severe Hot Flashes Following Clinical Trial Participation
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand name Lynkuet), developed by Bayer, for the treatment of moderate to severe vasomotor symptoms (hot flashes) associated with menopause. SCRC participated in multiple clinical trials evaluating elinzanetant, contributing to the pivotal data that helped support its approval.
nexttech-news.com
October 31, 2025 at 9:19 PM
Seattle Clinical Research Center Recognizes FDA Approval of Elinzanetant (Lynkuet) for Moderate to Severe Hot Flashes Following Clinical Trial Participation
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand…
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand…
Seattle Clinical Research Center Recognizes FDA Approval of Elinzanetant (Lynkuet) for Moderate to Severe Hot Flashes Following Clinical Trial Participation
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand…
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand…
Seattle Clinical Research Center Recognizes FDA Approval of Elinzanetant (Lynkuet) for Moderate to Severe Hot Flashes Following Clinical Trial Participation
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand name Lynkuet), developed by Bayer, for the treatment of moderate to severe vasomotor symptoms (hot flashes) associated with menopause. SCRC participated in multiple clinical trials evaluating elinzanetant, contributing to the pivotal data that helped support its approval.
nexttech-news.com
October 31, 2025 at 9:18 PM
Seattle Clinical Research Center Recognizes FDA Approval of Elinzanetant (Lynkuet) for Moderate to Severe Hot Flashes Following Clinical Trial Participation
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand…
Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand…
New Relief For Women In Menopause. Elinzanetant to be marketed as Lynkuet by Baye is an oral neurokinin/tachykinin antagonist that normalizes thermal and sleep regulation. #women #elinzanetant #Lynkuet #menopaue #hotflashes #nightsweats
October 31, 2025 at 5:52 AM
New Relief For Women In Menopause. Elinzanetant to be marketed as Lynkuet by Baye is an oral neurokinin/tachykinin antagonist that normalizes thermal and sleep regulation. #women #elinzanetant #Lynkuet #menopaue #hotflashes #nightsweats